AI assistant
Streamex Corp. — Director's Dealing 2015
Jul 20, 2015
35540_dirs_2015-07-20_65211c48-1f93-4cc2-8750-b81e44e0ea4a.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: BioSig Technologies, Inc. (BSGM)
CIK: 0001530766
Period of Report: 2015-07-20
Reporting Person: Tanaka Roy T (Director)
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock, $0.001 par value per share | 25000 | Direct |
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Options to Purchase Common Stock | $2.00 | 2019-07-18 | Common Stock (239642) | Direct | |
| Options to Purchase Common Stock | $2.50 | 2021-09-01 | Common Stock (479285) | Direct | |
| Options to Purchase Common Stock | $2.50 | 2021-09-01 | Common Stock (125000) | Direct | |
| Options to Purchase Common Stock | $2.53 | 2025-06-22 | Common Stock (50000) | Direct |
Footnotes
F1: The options vested 119,821 on July 18, 2013, the first anniversary of the grant, and 119,821 on July 18, 2014, the second anniversary of the grant. As of the date of this report, the options are vested and exercisable as to all 239,642 underlying shares.
F2: The options vest in 8 consecutive quarterly installments beginning three months from September 1, 2014, the date of the grant. As of the date of this report, the options are vested and exercisable as to 179,733 underlying shares.
F3: The options vest in 12 consecutive monthly installments beginning one month from June 22, 2015, the date of the grant. As of the date of this report, the options are vested and exercisable as to zero underlying shares.